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A B S T R A C T
Novel enzyme-luminescence method is used for the rapid and sensitive in vitro detection of natural
neurotoxins (e.g., shellﬁsh and mushroom toxins) using model brain cells. Paralytic shellﬁsh poisons
gonyautoxins (e.g., GTX2,3 and GTX1,4) were detected at 1 nM level by their inhibition of glutamate
release from C6 glioma cells upon drug stimulation (IC50: GTX2,3 = 30 nM and GTX1,4 = 8 nM). Activation
of glutamate release from C6 cells by ibotenic acid (a mushroom toxin) was also evaluated (EC50 = 10 nM).
The method was tested for real-time detection of glutamate release from primary rat cortical neurons.
Dose-dependent effects of KCl (0–200 mM) and NMDA on glutamate release from primary cortical
neurons were studied. The effects of different culture conditions on K+-depolarization-induced
glutamate release were also investigated. The method may be applicable to screening of drugs and toxins,
and ﬁnding glutamatergic neurons in brain slices without in situ staining.
ã 2016 The Author. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Marine poisons (e.g., paralytic shellﬁsh poisons) and mushroom
toxins (e.g., ibotenic acid) are extremely neurotoxic compounds
due to their potent toxicity to the nervous systems of humans. A
number of paralytic shellﬁsh poisons (PSPs) are known to be
responsible for the inhibition of glutamate release from cells.
Ibotenic acid, isolated from Amanita muscaria and Amanita
pantherina also stimulates glutamatergic neurons or glial cells
through N-methyl-D-aspartic acid (NMDA) receptor-mediated
elevation of intracellular Ca2+, which can lead to exocytosis of L-
glutamate release from cells [1–3]. Glutamate, a principal
excitatory neurotransmitter [4,5–7], is responsible for several
neurological disorders, including strokes, epilepsy, schizophrenia,
Alzheimer’s disease, and Parkinson’s disease [8,9]. Therefore, the
natural toxins such as marine poisons and mushroom toxins can be
detected indirectly by in vitro monitoring of extracellular L-
glutamate release. The chemical structures of gonyautoxins (e.g.,
GTX1, GTX2, GTX3, GTX4) and ibotenic acid (a mushroom toxin) are
shown in Scheme 1.
Voltage-dependent Na+ channel is critical for depolarization
and conduction in most excitable cells. Paralytic shellﬁsh toxins, a* Fax: +973 1768 0935.
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2215-017X/ã 2016 The Author. Published by Elsevier B.V. This is an open access article unfamily of potent neurotoxins block the voltage-gated Na+ channel
(VGSC). A schematic illustration of the induction mechanism of the
activator (e.g., veratridine (VTRD) which activates voltage-depen-
dent Na+ channels) and the inhibition mechanism of shellﬁsh
toxins (e.g., GTX2,3, GTX1,4 which block Nav1.4) of L-glutamate
release from a glutamatergic nerve cell or a glial cell is depicted by
numbers in squares in Scheme 2. The activation of the NMDA
receptor is also important in the release of neurotransmitters, such
as L-glutamate [1–3,10–12]. A schematic representation of the
action mechanisms of the NMDA receptor agonists (e.g., ibotenic
acid and NMDA) is depicted by numbers in circles in Scheme 2.
NMDA and ibotenic acid are speciﬁc agonists for the NMDA
receptors and they help to increase intracellular concentration of
Ca2+ ions as well as the release of L-glutamate from cells. However,
only a very few studies have been conducted on the effects of
ibotenic acid on NMDA receptors on the release of glutamate [1–3].
The effects of NMDA are normally determined using ﬂuorescence
microscopy with a calcium indicator [10]. However, this technique
is labor intensive as the indicator reagent should be loaded into the
cell bodies, and any excess of the reagent should be removed by
washing each time.
Several analytical techniques have been proposed to detect
natural neurotoxins, such as HPLC with pre- and post-column
derivatization [13,14], thin-layer chromatography (TLC) [15],
ﬂuorometry [16], cell bioassay [17], ﬂow cytometry [18],der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Scheme 1. Chemical structures of (a) paralytic shellﬁsh poisons (e.g., GTX1, GTX2, GTX3, GTX4), and (b) ibotenic acid.
Scheme 2. Schematic representation of mechanisms of the release of L-glutamate from C6 cells by gonyautoxins, a Na+ channel activator, and NMDA receptor agonists.
Veratridine activates voltage-dependent Na+ channels while ibotenic acid and NMDA activate the NMDA receptor, thereby helping trigger exocytosis of neurotransmitters,
such as L-glutamate from the cells through membrane depolarization and the increase of the intracellular Ca2+ concentration. Shellﬁsh toxins (e.g., GTX2,3 and GTX1,4) block
voltage-dependent Na+ channels inhibiting the release of L-glutamate.
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hemolysis [22], electrochemical methods [23], electrophoretic
method [24], and ELISA [25,26]. An ELISA test kit for detectingTable 1
Pros and cons of conventional and enzyme luminescence methods.
Method of analysis Pros and cons
1. Conventional techniques: HPLC, thin-layer
chromatography
(TLC), ﬂuorometry, cell bioassay, ﬂow
cytometry, neurophysiological
methods, capillary electrophoresis,
hemolysis, Elisa, electrochemical methods, and
electrophoretic method
2. Enzyme-luminescence technique
Not simple and easy to operate, low
time monitoring is limited due to th
methods, relatively poor spatial res
Simple and easy to use, highly sele
labor costs, applicable for screenin
immunostaining, may be suitable t
differentiation, neurotransmitter dysaxitoxin in shellﬁsh is also commercially available (RIDASCREEN1
Saxitoxin and RIDASCREEN1FAST Saxitoxin; r-Biopharm AG). The
pros and cons of these methods is outlined in Table 1. Although aller sample throughput, labor intensive nature, highly selective and sensitive, real-
e long time required for analysis, staining of the cells with dye is required for some
olution
ctive and sensitive, high sample throughput, good for real-time detection, lower
g of drugs and toxins, has potential in ﬁnding glutamatergic neurons without
o investigate the effects of various growth factors and chemicals on neuronal
namics, neurodegeneration, and synaptogenesis
Scheme 3. Enzyme-luminol reactions for L-glutamate detection.
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natural neurotoxins, there still remains a strong interest in ﬁnding
alternative methods for the detection of these toxins more rapidly
and sensitively.
Shinohara and co-workers including the author have proposed
a novel enzyme-luminescence technique to detect L-glutamate
sensitively and rapidly based on model brain cells (C6 glioma cells)
[27,28–30]. The principle of enzyme-luminescence technique, in
which L-glutamate is oxidized with glutamate oxidase to produce
H2O2 that reacts with luminol to generate chemiluminescence in
the presence of horseradish peroxidase, is depicted in Scheme 3.
In the ﬁrst part of this study, the applicability of this system for
in vitro model cell-based detection of natural neurotoxins (e.g.,
paralytic shellﬁsh poisons and mushroom toxin) are demonstrat-
ed. In this procedure, racemic mixtures of the marine toxins
GTX2,3 and GTX1,4 were administered to C6 glioma cells
separately to evaluate the inhibition effects of these toxins on
the release of glutamate from the cells upon stimulation by VTRD.
Ibotenic acid, a NMDA receptor agonist was administered to C6
cells to induce the release of glutamate. The potency of shellﬁsh
poisons and the mushroom toxin was compared by calculating IC50
and EC50 values, respectively. In the second part of the study, the
method is used for the real-time detection of glutamate releaseFig. 1. Phase contrast microscopic images of cultured rat cortical neurons at day 2, 3, and
sequentially as depicted in Scheme 3. Primary cortical neurons are differentiated into from primary rat cortical neurons instead of model cells. Dose-
dependent excitatory effects of KCl and NMDA on the glutamate
release are also presented. In addition, the effects of different
culture conditions on the KCl-induced glutamate release are
investigated.
2. Experimental
2.1. Reagents and chemicals
Luminol (5-amino-2,3-dihydro-1,4-phthalazinedione), KCl, glu-
cose, kanamycin sulfate and sodium glutamate monohydrate were
purchased from Wako Pure Chemicals Industries, Ltd. (Osaka,
Japan). L-Glutamate oxidase from Streptomyces sp. X-119-6 was
obtained from Yamasa Corporation (Choshi, Japan). Peroxidase
(POD) from horseradish was purchased from Toyobo Co., Ltd.
(Osaka, Japan). Fetal calf serum was obtained from ICN Biomedical,
Inc. Ham’s F10 medium powder, horse serum, DMEM, and
penicillin–streptomycin were obtained from GIBCO. Racemic
mixtures of the gonyautoxins (GTX), including GTX2,3 and
GTX1,4 were received as a gift from Kitasato University, Japan.
a-Amino-3-hydroxy-5-isoxazoleacetic acid (ibotenic acid) from
mushrooms, modiﬁed Hank’s balanced salt (HBSS) powder, 4. Three different culture conditions, (i.e., DMEM, TIS with Ara-c, and TIS) were used
glutamatergic neurons.
Scheme 4. Different media were used during culturing of primary cortical neurons
to differentiate them into glutamatergic neurons.
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cytosine arabinoside (Ara-C), albumin from bovine serum, DNase
I, trypsin inhibitor and N-methyl-d-aspartic acid (NMDA) were
purchased from Sigma.
2.2. C6 Glioma cell culture
Rat model cells (C6 glioma cells- JCRB9096 and passage number
45) were obtained from Health Science Research Resources Bank,
Osaka, Japan. Cells were grown in a T-25 ﬂask with Ham’s F10
medium supplemented with 15% (v/v) horse serum, 2.5% (v/v) fetal
calf serum and 1% penicillin–streptomycin at 37 C with 5% CO2 in
air. Passages of the cells were performed every fourth day using
0.25% trypsin—EDTA for detaching the cells for the duration of cell
growth. 24 h prior to the cell assay, 4-day-old cells were inoculated
at a density of 1 106 cells/mL into a 24-well plate.
2.3. Primary cultures of cortical neurons and differentiation
Primary cultures of cortical neurons were prepared from
Sprague–Dawley rats (Japan SLC, Hamamatsu, Japan) at embryonic
day 17 or 18 (E17 or E18). In brief, small pieces of cerebral cortex
were treated with 0.125% trypsin (DIFCO) and 1 mM EDTA for
15 min at 37 C and were thoroughly dissociated in DMEM. After
centrifugation, the cell pellet was treated with 0.004% DNase I and
0.03% trypsin inhibitor, and the suspended cells were seeded at
1 106 cells/mL in a poly-L-lysine-coated 24-well plate. The cells
were grown for 2 days in DMEM (supplemented with 10% fetal calf
serum and 100 mg/mL kanamycin sulfate) in a 10% CO2 incubator.Fig. 2. Effects of GTX2,3 on the L-glutamate response upon stimulation by veratridine (0.5
and the absence of GTX2,3. (a) Time courses of luminescence intensity monitoring of L
concentrations (0–10 mM). (b) Dose-response inhibitory effects of GTX2,3 on the L-glutam
represent the mean  SD of six experiments at each concentration.The medium was then replaced with serum-free of DMEM
supplemented with glucose (4.5 mg/mL), transferrin (5 mg/mL),
insulin (5 mg/mL), sodium selenite (5 ng/mL), bovin serum albumin
(1 mg/mL), and kanamycin sulfate (100 mg/mL) (TIS medium).
Cytosine arabinoside (Ara-C) (ﬁnal conc. 2 mM) was also added into
TIS medium to prevent the proliferation of glial cells. After 1 d of
incubation with the TIS medium, the medium was replaced again
with fresh TIS medium but devoid of Ara-C. The morphology of
cultured neurons is shown in Fig. 1. The L-glutamate release from
primary cortical neurons was monitored by evoking KCl or NMDA
using an enzyme luminescence method. A scheme depicting the
use of different media during culturing is shown in Scheme 4. The
rate of differentiation from primary neurons into glutamatergic
neurons is thought to be high when three media are used
sequentially.
2.4. Monitoring of assay of natural neurotoxins using C6 glioma cells
The culture medium was ﬁrst removed from each well and C6
cells were washed twice with warm (37 C) Hank’s solution. The
cells were then incubated separately for 10 min in the presence and
absence of paralytic shellﬁsh poisons (e.g., GTX2,3 and GTX1,4)
with 270 mL Hank’s solution (pH 7.4) supplemented with POD
(64 U/mL), luminol (0.05 mM) and L-glutamate oxidase (17 U/mL)
prior to stimulation. The cells were stimulated by auto-injection of
30 mL solution of the activator, veratridine, NMDA or ibotenic acid
using a luminescence plate-reader (FLUOstar OPTIMA, BMG
LABTECH, Germany). Hank’s solution (pH 7.4, 30 mL) was injected
as a stimulant for the control experiments.
2.5. Assay of the release of L-glutamate in real-time from rat cortical
neurons
The culture medium was ﬁrst removed from each well and the
cortical neurons were washed twice with warm (37 C) Hank’s
solution. The cells were then incubated for 20 min with 270 mL
measurement solution (205 mL Hank’s solution, 30 mL POD, 30 mL
luminol and 5 mL L-glutamate oxidase) prior to stimulation. The
cells were stimulated by injection of 30 mL solution of either K+ or
NMDA using a luminescence plate-reader. Hank’s solution was
injected as a stimulant for the control experiments. mM). C6 glioma cells were incubated for 10 min prior to stimulation in the presence
-glutamate release from C6 cells in the presence and absence of GTX2,3 at several
ate response to veratridine (0.5 mM) at the indicated concentrations in (a). All points
Fig. 3. Effects of GTX1,4 on the L-glutamate response to veratridine (0.5 mM). C6 glioma cells were incubated for 10 min in the presence and absence of GTX1,4 prior to
stimulation. (a) Time courses of luminescence intensity indicating L-glutamate release from C6 cells in the presence and absence of GTX1,4 at several concentrations (0–
10 mM). (b) Dose-dependent inhibitory effects of GTX1,4 on the release of L-glutamate to veratridine (0.5 mM) at the indicated concentrations in (a). Data are mean  SD of six
determinations at each concentration.
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After the assay of glutamate release, the solution was replaced
with 300 mL Hank’s solution and the cells were disrupted by either
sonication (power 7, 40 s) or freezing (20 C, overnight). The
sample was separated following centrifugation (13.2  103 rpm,Fig. 4. Effects of NMDA receptor agonists including mushroom toxin and NMDA on the L-g
indicating L-glutamate release from C6 cells upon stimulations by ibotenic acid, and NM
10 mM), and (c) NMDA (0- 200 mM) activators on the release of L-glutamate from the c
mean  SD of six determinations at each concentration.6 min) by ﬁltration using a membrane ﬁlter (pore size 0.22 mM).
For recoding the L-glutamate residue, the measurement solution
supplemented with Hank’s buffer (pH 7.4, 205 mL), 64 U/mL POD
(30 mL), 0.05 mM luminol (30 mL), and 17 U/mL L-glutamate
oxidase (5 mL) was added to each well of a 24-well plate. Puriﬁed
sample solution (30 mL) was injected into the wells of the 24-welllutamate responses from C6 glioma cells. (a) Time courses of luminescence intensity
DA at the indicated concentrations. Dose-dependent effects of (b) ibotenic acid (0–
ells. Hank’s solution was used as a stimulant for the control experiments. Data are
Fig. 5. Real-time monitoring of L-glutamate release from primary cortical neurons. (a) Dose-dependent effects of KCl at several concentrations (0–200 mM) on the release of L-
glutamate from cortical neurons. (b) Released and unreleased glutamate from neurons due to the effects of KCl at each concentration in (a). (c) Percentage release of glutamate
due to the effects of KCl at each concentration in (a). All points are mean  SD of four measurements at each concentration.
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reaction and luminescence was detected using a luminescence
plate-reader equipped with a highly sensitive photomultiplier
tube.
3. Results and discussion
3.1. Effects of paralytic shellﬁsh toxins on veratridine-induced
glutamate release from C6 cells
In order to investigate the effects of paralytic shellﬁsh toxins,
the cells were pretreated separately with racemic mixtures of the
gonyautoxins, including GTX2,3 and GTX1,4, for 10 min prior to
stimulation with veratridine (ﬁnal conc., 0.5 mM), and the
glutamate release from the cells was monitored in real-time.
Fig. 2a shows time courses of L-glutamate response measured by
the enzyme-luminescence method in the presence and absence of
GTX2,3 at the indicated concentrations. Fig. 2b shows a semi-
logarithmic plot of the luminescence peak intensity corresponding
to veratridine-evoked L-glutamate release in the same experi-
ments. Similarly, Fig. 3a and b shows the time courses of L-
glutamate response and a semi-logarithmic plot of the lumines-
cence peak intensity, respectively, in the presence and absence of
GTX1,4 at the indicated concentrations. The results indicate that
increasing concentrations of both GTX2,3 and GTX1,4 progressivelyinhibit the veratridine-induced release of glutamate. Several
studies have suggested that gonyautoxins block Nav1.4 channel,
which may decrease or delay neuronal depolarization as well as
glutamate release [17,18,23,31] The data reported here support this
phenomena.
The calculated IC50 values for GTX2,3 and GTX1,4 to inhibit
veratridine-induced glutamate release are 30 nM and 8 nM,
respectively, which are higher than those reported by Choudhary
et al. [23]. This discrepancy is probably due to the difference of
both the method of analysis and the cells used. However, the
results are consistent with the data reported previously [23]
showing that GTX1,4 is the more potent paralytic shellﬁsh toxin for
blocking voltage-gated Na+ channels as compared to GTX2,3.
3.2. Effects of ibotenic acid on the release of L-glutamate from C6 cells
Ibotenic acid, isolated from mushrooms, is a powerful natural
neurotoxin that can bind NMDA receptors and keep them open
[1,2–4]. The activation of NMDA receptors promote the inﬂux of
cations (e.g., Na+, Ca2+), which can lead to membrane depolariza-
tion. This, in turn, can help trigger exocytosis of neurotransmitters
such as L-glutamate [1,2,3,10,12]. The C6 glioma cells were
stimulated by ibotenic acid to evaluate the effects of the natural
toxin on NMDA-receptor-mediated L-glutamate release. The
potency of this mushroom toxin was compared with that of
Fig. 6. Real-time monitoring of L-glutamate release from primary cortical neurons. (a) Dose-dependent effects of NMDA at several concentrations (0–200 mM) on the release
of L-glutamate from the neurons. (b) Released and unreleased glutamate from neurons due to the effects of NMDA at each concentration in (a). (c) Percentage release of
glutamate due to the effects of NMDA at each concentration in (a). All points are mean  SD of four measurements at each concentration.
S.M. Zakir Hossain / Biotechnology Reports 9 (2016) 57–65 63NMDA, a speciﬁc well-known agonist of the NMDA receptor. Fig. 4a
shows the time courses of L-glutamate release evoked by ibotenic
acid and NMDA at the indicated concentrations. The luminescence
peak intensities are signiﬁcantly higher for both cases than the
control, which is consistent with that of the previous reports [1–
3,10,12].Fig. 7. Effects of different culture conditions on the L-glutamate response to KCl. (100 mM
shown. All points are mean  SD of four measurements at each concentration.The higher luminescence peak intensity (peak height) is most
probably due to either the increase of H2O2 produced by the L-
glutamate efﬂux upon stimulation or the oxidation of stimulants
(e.g., ibotenic acid, NMDA) themselves by L-glutamate oxidase. The
stimulation experiment was conducted using either ibotenic acid
or NMDA in the absence of cells to conﬁrm the speciﬁcity. The). Percentage release of glutamate due to the effects of different culture media is also
64 S.M. Zakir Hossain / Biotechnology Reports 9 (2016) 57–65results (not shown) are similar to those of the control experiments,
indicating that ibotenic acid and NMDA are not oxidized by L-
glutamate oxidase. Therefore, the observed high luminescence
intensity is due to the release of L-glutamate from the cells.
Fig. 4b shows a semi-logarithmic plot of the dose-dependence
of ibotenic acid on the release of L-glutamate from C6 cells, in
which the luminescence peak intensity (peak height) increases
with increasing ibotenic acid concentration. The data also indicate
that the minimum level of ibotenic acid that evokes a distinguish-
able luminescence response from cells over the control is 1 nM.
Similarly, Fig. 4c shows the dependence of the luminescence peak
intensity (peak height) on concentration upon stimulation with
NMDA (0–200 mM). Saturated level is 50 mM NMDA and a much
higher concentration of glutamate is released with this dose as
compared with the control. Furthermore, the EC50 values for
ibotenic acid- and NMDA-induced glutamate release were
calculated to be 10 nM and 22 mM, respectively. The results
demonstrate that ibotenic acid is a more potent stimulant for the
activation of NMDA receptors than NMDA. Moreover, the binding
afﬁnity of ibotenic acid to NMDA receptors is higher than that of
NMDA. The data are consistent with the results reported
previously [2,12].
3.3. Real-time monitoring of L-glutamate release from primary cortical
neurons
The effects of two types of stimulants, such as KCl and NMDA on
L-glutamate release from primary cortical neurons were also
investigated. The luminescence peak appeared rapidly, within a
few seconds, after the injection of either KCl or NMDA solution.
Fig. 5a indicates that the luminescence peak intensity depends on
the concentration of KCl. The data indicate that the luminescence
intensity reaches a maximum at about 100 mM KCl, which is
consistent with the observations in previous reports [27,32–34]
Residue of glutamate was also measured after breaking the cells
following centrifugation and ﬁltration. The total amount of
glutamate (released + unreleased) from cortical neurons deter-
mined in terms of luminescence peak intensities is shown in
Fig. 5b. Fig. 5c shows the percentage of glutamate released as a
function of the concentration of KCl, where the maximum
glutamate release was observed at 100 mM KCl.
Fig. 6a shows the dependence of the luminescence peak
intensity on concentration upon stimulation with NMDA, where
the peak intensity reaches a maximum at an NMDA concentration
of 100 mM. Fig. 6b shows a bar chart indicating the total glutamate
response. Fig. 6c shows the percentage of glutamate released as a
function of the concentration of NMDA, where the maximum
amount of glutamate released was observed at 50–100 mM NMDA.
3.4. Effects of different culture conditions on glutamate release due to
depolarization induced by K+
The primary cortical neurons were grown separately under
different culture conditions, (i.e., DMEM + TIS with Ara-C + TIS,
DMEM only, and DMEM + TIS), and the neurons were stimulated
with a high concentration of KCl (100 mM) to monitor the
glutamate released from the neurons. Fig. 7 shows the peak
intensities due to the released and residual glutamate at different
culture conditions. The percentage of glutamate released in the
presence of all three media, two media, and one medium were
calculated to be 38%, 32%, and 33%, respectively. The total amount
of glutamate released in the presence of all three media is high
compared to that of the other two culture conditions. This is
probably due to the high rate of differentiation from primary
neurons into glutamatergic neurons when three media are used
sequentially. The increased glutamate released upon stimulationwith an agonist may be a good marker of differentiation in primary
cortical neurons, which is truly a dye free marker. A majority of
conventional techniques used to monitor neuronal differentiation
in vitro are based on immunostaining and are dependent on a
ﬂuorescent or radioactive dye [35–37]. Thus, the enzyme-
luminescence method may be a useful tool in the evaluation of
neuronal differentiation ratio non-invasively, in real-time and
independent of any ﬂuorescent or radioactive probes.
4. Conclusion
The applicability of the enzyme-luminescence method reported
earlier for in vitro screening of natural neurotoxins is demonstrat-
ed. Racemic mixtures of the gonyautoxins, containing GTX2,3 and
GTX1,4, were used to evaluate their inhibition of the release of
glutamate from the C6 glioma cells. The activation of the release of
glutamate from C6 cells by ibotenic acid (a mushroom toxin) was
also evaluated. In order to compare the potency of these toxins,
EC50 or IC50 values were calculated. Furthermore, the enzyme-
luminescence method is useful for the in vitro detection of the
release of L-glutamate from primary cortical neurons. This novel
detection technique may also be used to determine the neuronal
differentiation ratio and to ﬁnd glutamatergic neurons in real-time
without immunostaining. Thus, the cell-response-based sensing
technology may ﬁnd widespread applications in screening of other
drugs and toxins that activate or inhibit either ion-channels or
receptors. This sensing tool may also have great potential for the
investigation of the effects of various growth factors and chemicals
on neuronal differentiation, neurotransmitter dynamics, neuro-
degeneration, and synaptogenesis.
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